Detlef Schuppan

Digital pathology and artificial intelligence in non-alcoholic steatohepatitis: current status and future directions.

V. Ratziu, E. Lawitz, M. Petitjean, 2023, Journal of hepatology.

An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

S. Cockell, I. Grypari, H. Cater, 2024, Nature metabolism.

Macrophages and platelets in liver fibrosis and hepatocellular carcinoma

Dominik Siegl, Martina Casari, Carsten Deppermann, 2023, Frontiers in immunology.

Short‐term reduction of dietary gluten improves metabolic‐dysfunction associated steatotic liver disease: A randomised, controlled proof‐of‐concept study

C. Labenz, A. Armandi, Manjusha Neerukonda, 2024, Alimentary pharmacology & therapeutics.

Vascular dysfunction and arterial hypertension in experimental celiac disease are mediated by gut-derived inflammation and oxidative stress

M. Oelze, S. Steven, P. Wenzel, 2024, Redox biology.